Exploring healthcare providers’ experiences with specialty medication and limited distribution networks
Integrated health-system specialty pharmacies (IHSSP) have shown high medication access, adherence, and provider satisfaction. The goal of this study was to explore healthcare providers’ experiences with specialty medications distributed via Limited Distribution Networks (LDN) that do not include IH...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377589/?tool=EBI |
| _version_ | 1811214591054577664 |
|---|---|
| author | Megan E. Peter Autumn D. Zuckerman Elizabeth Cherry David G. Schlundt Kemberlee Bonnet Nisha Shah Tara N. Kelley |
| author_facet | Megan E. Peter Autumn D. Zuckerman Elizabeth Cherry David G. Schlundt Kemberlee Bonnet Nisha Shah Tara N. Kelley |
| author_sort | Megan E. Peter |
| collection | DOAJ |
| description | Integrated health-system specialty pharmacies (IHSSP) have shown high medication access, adherence, and provider satisfaction. The goal of this study was to explore healthcare providers’ experiences with specialty medications distributed via Limited Distribution Networks (LDN) that do not include IHSSPs. We investigated healthcare providers’ perceived impact of LDNs on clinic workflow, clinical practice, and patient outcomes. Interviews and focus groups were conducted with fourteen healthcare providers from four outpatient specialty clinics at an academic health system with an IHSSP. Qualitative analysis using an iterative inductive/deductive approach of coded transcripts was used to identify themes. Participants discussed requirements and barriers to communicating with insurance providers, drug manufacturers, and external pharmacies; time and effort required to navigate LDNs and impact on workload and clinic workflow; financial awareness of medication costs and methods for communication about financial information with patients; and advocating for patients to ensure access to necessary therapy and avoid missed doses or treatment lapse. Participants reported barriers to navigating LDNs that can interfere with clinic workflow and patient care. IHSSPs may reduce clinic burden by helping patients access, afford, and remain on therapy. |
| first_indexed | 2024-04-12T06:07:15Z |
| format | Article |
| id | doaj.art-627f35e2017047ef809dba319602e9ed |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T06:07:15Z |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-627f35e2017047ef809dba319602e9ed2022-12-22T03:44:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01178Exploring healthcare providers’ experiences with specialty medication and limited distribution networksMegan E. PeterAutumn D. ZuckermanElizabeth CherryDavid G. SchlundtKemberlee BonnetNisha ShahTara N. KelleyIntegrated health-system specialty pharmacies (IHSSP) have shown high medication access, adherence, and provider satisfaction. The goal of this study was to explore healthcare providers’ experiences with specialty medications distributed via Limited Distribution Networks (LDN) that do not include IHSSPs. We investigated healthcare providers’ perceived impact of LDNs on clinic workflow, clinical practice, and patient outcomes. Interviews and focus groups were conducted with fourteen healthcare providers from four outpatient specialty clinics at an academic health system with an IHSSP. Qualitative analysis using an iterative inductive/deductive approach of coded transcripts was used to identify themes. Participants discussed requirements and barriers to communicating with insurance providers, drug manufacturers, and external pharmacies; time and effort required to navigate LDNs and impact on workload and clinic workflow; financial awareness of medication costs and methods for communication about financial information with patients; and advocating for patients to ensure access to necessary therapy and avoid missed doses or treatment lapse. Participants reported barriers to navigating LDNs that can interfere with clinic workflow and patient care. IHSSPs may reduce clinic burden by helping patients access, afford, and remain on therapy.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377589/?tool=EBI |
| spellingShingle | Megan E. Peter Autumn D. Zuckerman Elizabeth Cherry David G. Schlundt Kemberlee Bonnet Nisha Shah Tara N. Kelley Exploring healthcare providers’ experiences with specialty medication and limited distribution networks PLoS ONE |
| title | Exploring healthcare providers’ experiences with specialty medication and limited distribution networks |
| title_full | Exploring healthcare providers’ experiences with specialty medication and limited distribution networks |
| title_fullStr | Exploring healthcare providers’ experiences with specialty medication and limited distribution networks |
| title_full_unstemmed | Exploring healthcare providers’ experiences with specialty medication and limited distribution networks |
| title_short | Exploring healthcare providers’ experiences with specialty medication and limited distribution networks |
| title_sort | exploring healthcare providers experiences with specialty medication and limited distribution networks |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377589/?tool=EBI |
| work_keys_str_mv | AT meganepeter exploringhealthcareprovidersexperienceswithspecialtymedicationandlimiteddistributionnetworks AT autumndzuckerman exploringhealthcareprovidersexperienceswithspecialtymedicationandlimiteddistributionnetworks AT elizabethcherry exploringhealthcareprovidersexperienceswithspecialtymedicationandlimiteddistributionnetworks AT davidgschlundt exploringhealthcareprovidersexperienceswithspecialtymedicationandlimiteddistributionnetworks AT kemberleebonnet exploringhealthcareprovidersexperienceswithspecialtymedicationandlimiteddistributionnetworks AT nishashah exploringhealthcareprovidersexperienceswithspecialtymedicationandlimiteddistributionnetworks AT tarankelley exploringhealthcareprovidersexperienceswithspecialtymedicationandlimiteddistributionnetworks |